Santos V, Pereira L, de Araujo J, Borges M, Brandao C, Santos L
Front Pharmacol. 2025; 15:1515462.
PMID: 39867661
PMC: 11757102.
DOI: 10.3389/fphar.2024.1515462.
Sultana T, Malik K, Raja N, Mashwani Z, Hameed A, Ullah R
ACS Omega. 2024; 9(24):25555-25574.
PMID: 38911815
PMC: 11190918.
DOI: 10.1021/acsomega.4c01316.
Nabawy A, Makabenta J, Park J, Huang R, Nayar V, Patel R
Environ Sci Nano. 2024; 11(2):637-644.
PMID: 38841652
PMC: 11149111.
DOI: 10.1039/d3en00372h.
Safari S, Barani M, Sadrmohammadi R
BMC Oral Health. 2024; 24(1):146.
PMID: 38297300
PMC: 10832096.
DOI: 10.1186/s12903-024-03880-z.
Pereira M, Rodrigues A, Amaral L, Corte-Real M, Santos-Pereira C, Castanheira E
Pharmaceutics. 2023; 15(8).
PMID: 37631376
PMC: 10458800.
DOI: 10.3390/pharmaceutics15082162.
Role of nanostructured lipid carriers in the expression alterations of ATP-binding cassette transporter genes in fluconazole-resistant .
Moazeni M, Saeedi M, Kelidari H, Roohi B, Hedayati M, Shokohi T
Bioimpacts. 2023; 12(6):561-566.
PMID: 36644547
PMC: 9809133.
DOI: 10.34172/bi.2022.23825.
Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review.
Ribeiro A, Dias A, Zille A
ACS Appl Nano Mater. 2022; 5(3):3030-3064.
PMID: 36568315
PMC: 9773423.
DOI: 10.1021/acsanm.1c03891.
Integrated Mycotoxin Management System in the Feed Supply Chain: Innovative Approaches.
Fumagalli F, Ottoboni M, Pinotti L, Cheli F
Toxins (Basel). 2021; 13(8).
PMID: 34437443
PMC: 8402322.
DOI: 10.3390/toxins13080572.
Nanocarriers of Miconazole or Fluconazole: Effects on Three-Species Biofilms and Cytotoxic Effects In Vitro.
Caldeirao A, Araujo H, Arias L, Ramirez Carmona W, Miranda G, Oliveira S
J Fungi (Basel). 2021; 7(7).
PMID: 34201635
PMC: 8305882.
DOI: 10.3390/jof7070500.
Effects of Antifungal Carriers Based on Chitosan-Coated Iron Oxide Nanoparticles on Microcosm Biofilms.
Caldeirao A, Araujo H, Tomasella C, Sampaio C, Oliveira M, Ramage G
Antibiotics (Basel). 2021; 10(5).
PMID: 34067527
PMC: 8155828.
DOI: 10.3390/antibiotics10050588.
Development of Nano-Antifungal Therapy for Systemic and Endemic Mycoses.
Martinez-Montelongo J, Medina-Ramirez I, Romo-Lozano Y, Gonzalez-Gutierrez A, Macias-Diaz J
J Fungi (Basel). 2021; 7(2).
PMID: 33672224
PMC: 7926374.
DOI: 10.3390/jof7020158.
Physics Comes to the Aid of Medicine-Clinically-Relevant Microorganisms through the Eyes of Atomic Force Microscope.
Ciesluk M, Deptula P, Piktel E, Fiedoruk K, Suprewicz L, Paprocka P
Pathogens. 2020; 9(11).
PMID: 33233696
PMC: 7699805.
DOI: 10.3390/pathogens9110969.
Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections.
Kischkel B, Rossi S, Santos S, Nosanchuk J, Travassos L, Taborda C
Front Cell Infect Microbiol. 2020; 10:463.
PMID: 33014889
PMC: 7502903.
DOI: 10.3389/fcimb.2020.00463.
Applications and Limitations of Dendrimers in Biomedicine.
Chis A, Dobrea C, Morgovan C, Arseniu A, Rus L, Butuca A
Molecules. 2020; 25(17).
PMID: 32882920
PMC: 7504821.
DOI: 10.3390/molecules25173982.
Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications.
Wnorowska U, Fiedoruk K, Piktel E, Prasad S, Sulik M, Janion M
J Nanobiotechnology. 2020; 18(1):3.
PMID: 31898542
PMC: 6939332.
DOI: 10.1186/s12951-019-0566-z.
Zinc Oxide Nanoparticles Cytotoxicity and Release from Newly Formed PMMA-ZnO Nanocomposites Designed for Denture Bases.
Cierech M, Wojnarowicz J, Kolenda A, Krawczyk-Balska A, Prochwicz E, Wozniak B
Nanomaterials (Basel). 2019; 9(9).
PMID: 31540147
PMC: 6781076.
DOI: 10.3390/nano9091318.
Susceptibility of microbial cells to the modified PIP-binding sequence of gelsolin anchored on the surface of magnetic nanoparticles.
Bucki R, Niemirowicz-Laskowska K, Deptula P, Wilczewska A, Misiak P, Durnas B
J Nanobiotechnology. 2019; 17(1):81.
PMID: 31286976
PMC: 6615188.
DOI: 10.1186/s12951-019-0511-1.
Artificial Saliva: Challenges and Future Perspectives for the Treatment of Xerostomia.
Lysik D, Niemirowicz-Laskowska K, Bucki R, Tokajuk G, Mystkowska J
Int J Mol Sci. 2019; 20(13).
PMID: 31261876
PMC: 6651665.
DOI: 10.3390/ijms20133199.
Screening and Antifungal Activity of a -Carboline Derivative against and .
Cruz K, Lima E, Silva M, de Souza E, Montoia A, Pohlit A
Int J Microbiol. 2019; 2019:7157845.
PMID: 30805002
PMC: 6362477.
DOI: 10.1155/2019/7157845.
Nanoparticles as a Solution for Eliminating the Risk of Mycotoxins.
Horky P, Skalickova S, Baholet D, Skladanka J
Nanomaterials (Basel). 2018; 8(9).
PMID: 30223519
PMC: 6164963.
DOI: 10.3390/nano8090727.